Reference
Jian H, et al. Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations: afatinib in ERBB+ lung squamous cell carcinoma. Anti-Cancer Drugs 30: 873-878, No. 8, Sep 2019. Available from: URL: http://doi.org/10.1097/CAD.0000000000000813
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1830, 19 (2020). https://doi.org/10.1007/s40278-020-85969-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85969-8